FFA
DNA icon

Farther Finance Advisors’s Ginkgo Bioworks DNA Stock Holding History

Farther Finance Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.05K Buy
608
+276
+83% +$2.31K ﹤0.01% 4695
2026
Q1 		$2.25K Sell
332
-507
-60% -$4.22K ﹤0.01% 4856
2025
Q4 		$6.97K Buy
839
+125
+18% +$1.35K ﹤0.01% 4143
2025
Q3 		$10.4K Buy
714
+649
+998% +$7.77K ﹤0.01% 3427
2025
Q2 		$731 Sell
65
-37
-36% -$287 ﹤0.01% 3964
2025
Q1 		$577 Buy
102
+37
+57% +$377 ﹤0.01% 3750
2024
Q4 		$638 Buy
65
+50
+333% +$429 ﹤0.01% 3386
2024
Q3 		$122 Sell
15
-1
-6% -$10 ﹤0.01% 3742
2024
Q2 		$207 Hold
16
– – ﹤0.01% 3488
2024
Q1 		$716 Sell
16
-44
-73% -$2.28K ﹤0.01% 2901
2023
Q4 		$4.06K Buy
+60
New +$3.67K ﹤0.01% 2078
2023
Q1 		– Sell
-7
Closed -$477 – 2370
2022
Q4 		$477 Buy
+7
New +$644 ﹤0.01% 1836

Other funds holding DNA

JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $689M AUM 16.24% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's DNA Position: Q2 2026 in Review

Farther Finance Advisors increased its Ginkgo Bioworks (DNA) stake by 83% in Q2 2026, buying an estimated $2.31K and bringing the position to 608 shares worth $6.05K. The position accounts for ﹤0.01% of the portfolio, ranked #4695.

Farther Finance Advisors first reported a position in DNA in Q4 2022 and has held it in 12 quarters since. The position peaked at $10.4K in Q3 2025. 19 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Farther Finance Advisors held 608 shares of Ginkgo Bioworks worth $6.05K as of Q2 2026.
  • Farther Finance Advisors bought 276 Ginkgo Bioworks shares in Q2 2026, an estimated $2.31K.
  • Ginkgo Bioworks made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4695 holding.
  • Farther Finance Advisors first reported a position in Ginkgo Bioworks in Q4 2022 and has held it in 12 quarters since.
  • Farther Finance Advisors's Ginkgo Bioworks position peaked at $10.4K in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.